• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过促进巨噬细胞 M2 极化和吞噬作用,降低 TMAO 水平可增强颈动脉粥样硬化斑块的稳定性。

Reduction of TMAO level enhances the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis.

机构信息

Department of Vascular Surgery, Shanghai Huashan Hospital, Fudan University, Shanghai 200040, China.

Department of General Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai 201399, China.

出版信息

Biosci Rep. 2021 May 28;41(6). doi: 10.1042/BSR20204250.

DOI:10.1042/BSR20204250
PMID:33969376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8176787/
Abstract

It has been demonstrated that trimethylamine N-oxide (TMAO) serves as a driver of atherosclerosis, suggesting that reduction of TMAO level might be a potent method to prevent the progression of atherosclerosis. Herein, we explored the role of TMAO in the stability of carotid atherosclerotic plaques and disclosed the underlying mechanisms. The unstable carotid artery plaque models were established in C57/BL6 mice. L-carnitine (LCA) and methimazole (MMI) administration were applied to increase and reduce TMAO levels. Hematoxylin and eosin (H&E) staining, Sirius red, Perl's staining, Masson trichrome staining and immunohistochemical staining with CD68 staining were used for histopathology analysis of the carotid artery plaque. M1 and M2 macrophagocyte markers were assessed by RT-PCR to determine the polarization of RAW264.7 cells. MMI administration for 2 weeks significantly decreased the plaque area, increased the thickness of the fibrous cap and reduced the size of the necrotic lipid cores, whereas 5-week of administration of MMI induced intraplate hemorrhage. LCA treatment further deteriorated the carotid atherosclerotic plaque but with no significant difference. In mechanism, we found that TMAO treatment impaired the M2 polarization and efferocytosis of RAW264.7 cells with no obvious effect on the M1 polarization. In conclusion, the present study demonstrated that TMAO reduction enhanced the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis.

摘要

已有研究表明,氧化三甲胺(TMAO)可促进动脉粥样硬化的发生,提示降低 TMAO 水平可能是预防动脉粥样硬化进展的有效方法。在此,我们探讨了 TMAO 在颈动脉粥样硬化斑块稳定性中的作用,并揭示了其潜在机制。通过在 C57/BL6 小鼠中建立不稳定颈动脉斑块模型,应用左卡尼汀(LCA)和甲巯咪唑(MMI)分别增加和降低 TMAO 水平。通过苏木精和伊红(H&E)染色、天狼猩红染色、Perl’s 染色、Masson 三色染色和 CD68 免疫组化染色进行颈动脉斑块的组织病理学分析。通过 RT-PCR 评估 M1 和 M2 巨噬细胞标志物,以确定 RAW264.7 细胞的极化情况。连续 2 周给予 MMI 可显著减少斑块面积,增加纤维帽厚度,减少坏死脂质核心的大小,而给予 5 周的 MMI 则会诱导斑块内出血。LCA 处理进一步恶化了颈动脉粥样硬化斑块,但无显著差异。在机制方面,我们发现 TMAO 处理会损害 RAW264.7 细胞的 M2 极化和吞噬作用,但对 M1 极化无明显影响。综上,本研究表明,降低 TMAO 水平通过促进巨噬细胞 M2 极化和吞噬作用增强了颈动脉粥样硬化斑块的稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/d52fc2691e0a/bsr-41-bsr20204250-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/83974186c5de/bsr-41-bsr20204250-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/1f70f2cb0a7c/bsr-41-bsr20204250-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/de3dd16d7a84/bsr-41-bsr20204250-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/8f4a8512ee43/bsr-41-bsr20204250-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/dc1898c0aa81/bsr-41-bsr20204250-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/c8a80fccba33/bsr-41-bsr20204250-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/7451f34862a5/bsr-41-bsr20204250-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/d52fc2691e0a/bsr-41-bsr20204250-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/83974186c5de/bsr-41-bsr20204250-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/1f70f2cb0a7c/bsr-41-bsr20204250-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/de3dd16d7a84/bsr-41-bsr20204250-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/8f4a8512ee43/bsr-41-bsr20204250-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/dc1898c0aa81/bsr-41-bsr20204250-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/c8a80fccba33/bsr-41-bsr20204250-g6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/7451f34862a5/bsr-41-bsr20204250-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85f/8176787/d52fc2691e0a/bsr-41-bsr20204250-g8.jpg

相似文献

1
Reduction of TMAO level enhances the stability of carotid atherosclerotic plaque through promoting macrophage M2 polarization and efferocytosis.通过促进巨噬细胞 M2 极化和吞噬作用,降低 TMAO 水平可增强颈动脉粥样硬化斑块的稳定性。
Biosci Rep. 2021 May 28;41(6). doi: 10.1042/BSR20204250.
2
HOXA5 induces M2 macrophage polarization to attenuate carotid atherosclerosis by activating MED1.HOXA5 通过激活 MED1 诱导 M2 型巨噬细胞极化来减轻颈动脉粥样硬化。
IUBMB Life. 2021 Sep;73(9):1142-1152. doi: 10.1002/iub.2515. Epub 2021 Jun 26.
3
Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.进展或消退的小鼠动脉粥样硬化斑块中有限的巨噬细胞位置动态变化-简短报告。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1702-1710. doi: 10.1161/ATVBAHA.118.311319.
4
CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.CXCL12 促进载脂蛋白 E 缺陷小鼠中平滑肌祖细胞介导的动脉粥样硬化病变的稳定。
Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):679-86. doi: 10.1161/ATVBAHA.112.301162. Epub 2013 Feb 7.
5
Correlation between SHP-1 and carotid plaque vulnerability in humans.SHP-1 与人颈动脉斑块易损性的相关性。
Cardiovasc Pathol. 2020 Nov-Dec;49:107258. doi: 10.1016/j.carpath.2020.107258. Epub 2020 Jun 24.
6
Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.丹参酮 IIA 和黄芪甲苷联合通过激活 PI3K/AKT 信号通路和抑制 TLR4/NF-κB 信号通路减轻 ApoE(-/-) 小鼠动脉粥样硬化斑块易损性。
Biomed Pharmacother. 2020 Mar;123:109729. doi: 10.1016/j.biopha.2019.109729. Epub 2019 Dec 27.
7
Huanglian Jiedu Decoction enhances the stability of atherosclerotic plaques through SLC2A1-mediated efferocytosis.黄连解毒汤通过 SLC2A1 介导向细胞吞噬作用增强动脉粥样硬化斑块的稳定性。
Int Immunopharmacol. 2024 Oct 25;140:112834. doi: 10.1016/j.intimp.2024.112834. Epub 2024 Aug 7.
8
Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.棕榈酰乙醇酰胺促进促修复巨噬细胞表型并减轻动脉粥样硬化斑块形成。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2562-2575. doi: 10.1161/ATVBAHA.118.311185.
9
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.MCC950对NLRP3炎性小体的抑制作用可减少载脂蛋白E缺乏小鼠的动脉粥样硬化病变发展——简要报告
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8.
10
Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe mice.APAC(一种双重抗血小板抗凝肝素蛋白聚糖模拟物)治疗可限制 Apoe 小鼠早期颈圈诱导的颈动脉粥样硬化斑块发展。
Atherosclerosis. 2024 Oct;397:118567. doi: 10.1016/j.atherosclerosis.2024.118567. Epub 2024 Aug 22.

引用本文的文献

1
Single-Cell Data and Weighted Correlation Network Analysis Revealed the Regulatory Mechanisms of Macrophages in Carotid Plaques.单细胞数据与加权相关网络分析揭示了颈动脉斑块中巨噬细胞的调控机制。
J Immunol Res. 2025 Jul 21;2025:9987367. doi: 10.1155/jimr/9987367. eCollection 2025.
2
Circadian rhythms of gut microbiota and plaque vulnerability: mechanisms and chrono-microbiota modulation interventions.肠道微生物群的昼夜节律与斑块易损性:机制及生物钟-微生物群调节干预措施
Gut Microbes. 2025 Dec;17(1):2532703. doi: 10.1080/19490976.2025.2532703. Epub 2025 Jul 12.
3
The Metabolite Indole-3-Acetic Acid of Bacteroides Ovatus Improves Atherosclerosis by Restoring the Polarisation Balance of M1/M2 Macrophages and Inhibiting Inflammation.

本文引用的文献

1
Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.血浆三甲胺 N-氧化物作为 ST 段抬高型心肌梗死患者斑块破裂的新型生物标志物。
Circ Cardiovasc Interv. 2019 Jan;12(1):e007281. doi: 10.1161/CIRCINTERVENTIONS.118.007281.
2
Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.三甲基胺 N-氧化物(TMAO)引起的动脉粥样硬化与胆汁酸代谢有关。
Lipids Health Dis. 2018 Dec 19;17(1):286. doi: 10.1186/s12944-018-0939-6.
3
Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.
卵形拟杆菌的代谢产物吲哚-3-乙酸通过恢复M1/M2巨噬细胞的极化平衡和抑制炎症来改善动脉粥样硬化。
Adv Sci (Weinh). 2025 Mar;12(11):e2413010. doi: 10.1002/advs.202413010. Epub 2025 Jan 22.
4
The gut microbiota in thrombosis.血栓形成中的肠道微生物群
Nat Rev Cardiol. 2025 Feb;22(2):121-137. doi: 10.1038/s41569-024-01070-6. Epub 2024 Sep 17.
5
The effect of intestinal flora metabolites on macrophage polarization.肠道菌群代谢产物对巨噬细胞极化的影响。
Heliyon. 2024 Aug 3;10(15):e35755. doi: 10.1016/j.heliyon.2024.e35755. eCollection 2024 Aug 15.
6
High-fat-diet-induced obesity promotes simultaneous progression of lung cancer and atherosclerosis in apolipoprotein E-knockout mice.高脂饮食诱导的肥胖促进载脂蛋白E基因敲除小鼠肺癌和动脉粥样硬化的同时进展。
Cancer Innov. 2024 Jun 5;3(4):e127. doi: 10.1002/cai2.127. eCollection 2024 Aug.
7
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence.膳食胆碱与心脏代谢紊乱的相互作用:当前证据综述。
Curr Nutr Rep. 2024 Jun;13(2):152-165. doi: 10.1007/s13668-024-00521-3. Epub 2024 Mar 1.
8
Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis.靶向肠道微生物群与免疫串扰:天然产物治疗动脉粥样硬化的潜在机制
Front Pharmacol. 2023 Sep 1;14:1252907. doi: 10.3389/fphar.2023.1252907. eCollection 2023.
9
The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review.三甲基胺 N-氧化物在动脉粥样硬化中的作用及其潜在的治疗方面:文献综述。
Biomol Biomed. 2023 Nov 3;23(6):936-948. doi: 10.17305/bb.2023.8893.
10
Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story.肠道分子在心脏代谢疾病中的作用:故事背后的机制。
Int J Mol Sci. 2023 Feb 8;24(4):3385. doi: 10.3390/ijms24043385.
髓过氧化物酶是一种有潜力的分子影像学和治疗靶点,可用于识别和稳定高危动脉粥样硬化斑块。
Eur Heart J. 2018 Sep 14;39(35):3301-3310. doi: 10.1093/eurheartj/ehy419.
4
Marked elevation in plasma trimethylamine-N-oxide (TMAO) in patients with mitochondrial disorders treated with oral l-carnitine.接受口服左旋肉碱治疗的线粒体疾病患者血浆三甲胺-N-氧化物(TMAO)显著升高。
Mol Genet Metab Rep. 2018 May 3;15:130-133. doi: 10.1016/j.ymgmr.2018.04.005. eCollection 2018 Jun.
5
Atherosclerosis and inflammation: overview and updates.动脉粥样硬化与炎症:概述与最新进展
Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252. doi: 10.1042/CS20180306. Print 2018 Jun 29.
6
Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions.局部递送 miR-21 稳定易损动脉粥样硬化病变中的纤维帽。
Mol Ther. 2018 Apr 4;26(4):1040-1055. doi: 10.1016/j.ymthe.2018.01.011. Epub 2018 Jan 31.
7
Vulnerable atherosclerotic plaque - a review of current concepts and advanced imaging.易损性动脉粥样硬化斑块——当前概念与先进成像技术综述
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Mar;162(1):10-17. doi: 10.5507/bp.2018.004. Epub 2018 Feb 21.
8
Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.三甲胺 N-氧化物通过 CD36 依赖性 MAPK/JNK 通路促进动脉粥样硬化。
Biomed Pharmacother. 2018 Jan;97:941-947. doi: 10.1016/j.biopha.2017.11.016. Epub 2017 Nov 7.
9
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.急性冠状动脉综合征中肠道微生物群依赖性三甲胺 N-氧化物:超越传统危险因素的心血管事件发生的预后标志物。
Eur Heart J. 2017 Mar 14;38(11):814-824. doi: 10.1093/eurheartj/ehw582.
10
Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome.氧化三甲胺通过激活ROS-TXNIP-NLRP3炎性小体诱导人脐静脉内皮细胞发生炎症和内皮功能障碍。
Biochem Biophys Res Commun. 2016 Dec 2;481(1-2):63-70. doi: 10.1016/j.bbrc.2016.11.017. Epub 2016 Nov 8.